Faron Pharmaceuticals reports promising phase 1 results from BEXMAB study

By Proactive Investors / March 18, 2024 / www.youtube.com / Article Link

Faron Pharmaceuticals Limited (AIM:FARN) chief executive Dr Markku Jalkanen joins Proactive's Stephen Gunnion with ...

Recent News

Equity highs and low credit spreads may be warning signs

August 10, 2026 / www.canadianminingreport.com

Gold stocks see strongest week in a decade

August 10, 2026 / www.canadianminingreport.com

Big Gold's strong Q2/26 results continue

August 03, 2026 / www.canadianminingreport.com

Gold stocks see moderate declines

August 03, 2026 / www.canadianminingreport.com

Market still expecting strong growth for major gold producers

July 27, 2026 / www.canadianminingreport.com

See all >